Disorders of Consciousness and Severe Brain Injury
Clinical research at Université de Liège includes treatment-focused studies in disorders of consciousness following coma and severe brain injury, with attention to patients who may show recovery-related responses to centrally acting therapies.
- Post-comatose consciousness recovery
- Severe brain injury rehabilitation
- Treatment responsiveness in DoC
The sponsor’s activity in this area centers on identifying patients who respond to pharmacological interventions that may alter arousal and awareness.
Neuropharmacology and Consciousness-Modulating Therapies
Research interests extend to apomorphine hydrochloride, ketamine, and zolpidem as agents studied for their effects on consciousness, arousal, and paradoxical neurological responses.
- Dopaminergic modulation
- Glutamatergic mechanisms
- Sleep-wake regulation
These studies address how different neuroactive compounds may influence responsiveness in patients with impaired consciousness.
Paradoxical Drug Responses and Personalised Neurology
The sponsor also investigates unusual responses to zolpidem across neurotypical volunteers, patients with disorders of consciousness, and individuals with acquired visual impairment, reflecting interest in inter-individual variability in neurological drug effects.
- Paradoxical arousal
- Individual response variability
- Neurological phenotyping
Work in this domain includes mechanisms linked to temporary improvement in awareness or vision in selected responders.
Vision Impairment and Neurological Recovery
Another area of interest concerns patients with partial or total acquired vision impairments, where research examines transient visual recovery associated with paradoxical pharmacological responses.
- Acquired visual loss
- Temporary vision restoration
- Central nervous system effects
This line of research connects sensory recovery with broader questions about how neurological function can be altered in selected patient groups.
